Press release BoxID: 265237 (Roche Diagnostics Deutschland GmbH)
  • Roche Diagnostics Deutschland GmbH
  • Sandhofer Str. 116
  • 68305 Mannheim
  • Contact person
  • Burkhard Ziebolz
  • +49 (8856) 60-4830

Roche Applied Science Opens Application Support Center in Shanghai

(PresseBox) (Shanghai, ) Roche Applied Science today announced the opening of the new Application Support Center (ASC) in Shanghai, China. Staffed with experts skilled in applying a broad range of technologies to a diverse range of life science research topics, the center will serve researchers across Asia Pacific in their daily work with technical advice.

Customers will be offered hotline support for all Roche Applied Science products free of charge. In support of today's researcher needs, Roche is strengthening technical support, and bringing it both culturally and geographically closer to customers in the Asia Pacific region. The objective is to accelerate projects of Roche customers. In the near future, the ASC will expand by opening lab facilities, providing laboratory support for customers' experiments and performing trainings and demos of Roche instruments.

This investment by RAS in Shanghai continues a trend of increasing Roche investment in Asia Pacific exemplified by Roche Pharma R & D operations in Shanghai, and the Roche Diagnostics Asia Pacific Training Center in Bangkok, Thailand.

"Roche is focused on innovation. Our objective is to support researchers, not only with innovative products, but also with excellent service, enabling faster discoveries in life science research," states Roland Diggelmann, Head of Roche Diagnostics APAC.

Roche Diagnostics Deutschland GmbH

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2008, Roche had over 80,000 employees worldwide and invested almost 9 billion Swiss francs in R&D. The Group posted sales of 45.6 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: